Skip to main content

Advocacy News

News and views on the regulatory, legislative, and political issues impacting ophthalmology in Washington, D.C., and around the United States

Image
HHS
Member exclusive - Locked
Featured News

The final rule from the Centers for Medicare & Medicaid Services (CMS) includes a 2.31% payment cut for physicians not participating in qualifying APMs and a 1.83% pay cut for qualifying Alternative Payment Model (APM) participants. 

Read the Story
Filters
Advocacy Issues
Image
Step therapy has to go
Member exclusive - Locked
October 29, 2026
Federal Watchdog to Investigate Step Therapy in Medicare Advantage Plans, at Academy’s Urging

The Academy met with the HHS Office of Inspector to continue pressing our concerns about step therapy. The meeting follows the OIG’s September 15 announcement that it will review how Medicare Advantage plans use prior authorization and step therapy for Part B drugs, a review the Academy urged.  
 

Member exclusive - Locked
January 21, 2026
Medicare Reintroduces Mandatory Drug Pricing Models

Ophthalmologists should continue buying and billing for eye drugs the same way. If patients' out-of-pocket costs go down, the amount Medicare pays physicians will go up to match.

Member exclusive - Locked
May 14, 2025
White House Issues Executive Order on Lowering Drug Prices

The order could tie U.S. prices to the lowest price paid by a select number of developed countries.

Member exclusive - Locked
June 21, 2023
HHS and MedPAC Reports Encourage Significant Changes to Part B Drug Payment

HHS and MedPAC Reports Encourage Significant Changes to Part B Drug Payment The Academy is monitoring congressional reaction to these reports given that the recommendations would impact ophthalmologists.

Member exclusive - Locked
January 18, 2023
CMS Announces Timeline for Negotiated Medicare Drug Pricing

The key provision from the Inflation Reduction Act is not expected to affect ophthalmic drugs in the short term.  

Member exclusive - Locked
December 9, 2020
Academy Urges HHS to Halt Most Favored Nation Drug Pricing Demonstration

We’re working to make sure that a demonstration plan that becomes effective Jan. 1 won’t limit patients’ access to treatment.

June 20, 2018
Academy to Feds: Step Therapy is Risky Drug Policy for Ophthalmology 

We're working to thwart proposals that could cost our patients their sight by offering other ways to lower drug costs